BACKGROUND AND OBJECTIVES: Due to their behavioral conditions and vulnerability, injection drug users (IDUs) are prone to multiple simultaneous or sequential infections with distinct HIV-1 subtypes and variants, making them a key population for molecular epidemiology surveillance. In the present study, we evaluated HIV-1 infection seroprevalence, genetic diversity and estimated incidence among IDUs and ex-injection drug users (ex-IDUs) from Rio de Janeiro, Brazil. STUDY DESIGN: Six hundred and eight IDUs and ex-IDUs, recruited between 1999 and 2001, were interviewed and agreed to donate 30 ml of blood. The serologic status for HIV infection was determined by two ELISAs and confirmed by IFA. CD4+ T-cell percentages were assessed by flow cytometry. HIV-1 positive samples were submitted to viral load quantification. DNA samples were PCR amplified and HIV-1 subtypes were determined using env and gag HMA. RESULTS AND CONCLUSIONS: Forty-eight (7.89%) individuals were seropositive for HIV-1 infection. The seroincidence of HIV-1 infection was estimated as 0.76%. HIV-1 env and gag subtyping identified 29 (69%) samples as belonging to subtype B, 7 (16.7%) to subtype F, and 6 (14.3%) discordant env/gag genomes infections, indicating the circulation of recombinant viruses in this population.
BACKGROUND AND OBJECTIVES: Due to their behavioral conditions and vulnerability, injection drug users (IDUs) are prone to multiple simultaneous or sequential infections with distinct HIV-1 subtypes and variants, making them a key population for molecular epidemiology surveillance. In the present study, we evaluated HIV-1 infection seroprevalence, genetic diversity and estimated incidence among IDUs and ex-injection drug users (ex-IDUs) from Rio de Janeiro, Brazil. STUDY DESIGN: Six hundred and eight IDUs and ex-IDUs, recruited between 1999 and 2001, were interviewed and agreed to donate 30 ml of blood. The serologic status for HIV infection was determined by two ELISAs and confirmed by IFA. CD4+ T-cell percentages were assessed by flow cytometry. HIV-1 positive samples were submitted to viral load quantification. DNA samples were PCR amplified and HIV-1 subtypes were determined using env and gag HMA. RESULTS AND CONCLUSIONS: Forty-eight (7.89%) individuals were seropositive for HIV-1 infection. The seroincidence of HIV-1 infection was estimated as 0.76%. HIV-1env and gag subtyping identified 29 (69%) samples as belonging to subtype B, 7 (16.7%) to subtype F, and 6 (14.3%) discordant env/gag genomes infections, indicating the circulation of recombinant viruses in this population.
Authors: Don C Des Jarlais; Jonathan P Feelemyer; Shilpa N Modi; Kamyar Arasteh; Holly Hagan Journal: Drug Alcohol Depend Date: 2012-01-17 Impact factor: 4.492
Authors: Gonzalo Bello; Paula C Aulicino; Dora Ruchansky; Monick L Guimarães; Cecilio Lopez-Galindez; Concha Casado; Hector Chiparelli; Carlos Rocco; Andrea Mangano; Luisa Sen; Mariza G Morgado Journal: Retrovirology Date: 2010-03-22 Impact factor: 4.602
Authors: Monica Malta; Monica M F Magnanini; Maeve B Mello; Ana Roberta P Pascom; Yohana Linhares; Francisco I Bastos Journal: BMC Public Health Date: 2010-06-07 Impact factor: 3.295
Authors: Yaxelis Mendoza; Gonzalo Bello; Juan Castillo Mewa; Alexander A Martínez; Claudia González; Claudia García-Morales; Santiago Avila-Ríos; Gustavo Reyes-Terán; Juan M Pascale Journal: PLoS One Date: 2014-01-13 Impact factor: 3.240
Authors: Monick L Guimarães; Ana Carolina P Vicente; Koko Otsuki; Rosa Ferreira F C da Silva; Moises Francisco; Filomena Gomes da Silva; Ducelina Serrano; Mariza G Morgado; Gonzalo Bello Journal: Retrovirology Date: 2009-04-22 Impact factor: 4.602